These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15205351)

  • 41. Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicity.
    Meynard D; Le Morvan V; Bonnet J; Robert J
    Oncol Rep; 2007 May; 17(5):1213-21. PubMed ID: 17390068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach.
    Huang RS; Duan S; Shukla SJ; Kistner EO; Clark TA; Chen TX; Schweitzer AC; Blume JE; Dolan ME
    Am J Hum Genet; 2007 Sep; 81(3):427-37. PubMed ID: 17701890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The feasibility of oligogenic combined segregation and linkage analysis in CEPH pedigrees.
    Daw EW; Yu R
    BMC Proc; 2007; 1 Suppl 1(Suppl 1):S108. PubMed ID: 18466448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemotherapeutic-induced apoptosis: a phenotype for pharmacogenomics studies.
    Wen Y; Gorsic LK; Wheeler HE; Ziliak DM; Huang RS; Dolan ME
    Pharmacogenet Genomics; 2011 Aug; 21(8):476-88. PubMed ID: 21642893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of genomic regions contributing to etoposide-induced cytotoxicity.
    Bleibel WK; Duan S; Huang RS; Kistner EO; Shukla SJ; Wu X; Badner JA; Dolan ME
    Hum Genet; 2009 Mar; 125(2):173-80. PubMed ID: 19089452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Linkage and association analyses of principal components in expression data.
    Hinrichs AL; Culverhouse R; Jin CH; Suarez BK
    BMC Proc; 2007; 1 Suppl 1(Suppl 1):S46. PubMed ID: 18466545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Linkage mapping of human polymorphic proteins identified by two-dimensional electrophoresis.
    Goldman D; O'Brien SJ; Lucas-Derse S; Dean M
    Genomics; 1991 Dec; 11(4):875-84. PubMed ID: 1686020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.
    Huang RS; Duan S; Bleibel WK; Kistner EO; Zhang W; Clark TA; Chen TX; Schweitzer AC; Blume JE; Cox NJ; Dolan ME
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9758-63. PubMed ID: 17537913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The power to detect genetic linkage for quantitative traits in the Utah CEPH pedigrees.
    Malhotra A; Cromer K; Leppert MF; Hasstedt SJ
    J Hum Genet; 2005; 50(2):69-75. PubMed ID: 15682273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genomic association/linkage of sodium lithium countertransport in CEPH pedigrees.
    Schork NJ; Gardner JP; Zhang L; Fallin D; Thiel B; Jakubowski H; Aviv A
    Hypertension; 2002 Nov; 40(5):619-28. PubMed ID: 12411453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of new genes involved in cisplatin resistance and their expression profile in 18 human tumor cell lines.
    Gosepath EM; Weykam S; Wiese M; Kassack MU
    Int J Clin Pharmacol Ther; 2005 Dec; 43(12):579-80. PubMed ID: 16372524
    [No Abstract]   [Full Text] [Related]  

  • 52. Genetic variants contributing to daunorubicin-induced cytotoxicity.
    Huang RS; Duan S; Kistner EO; Bleibel WK; Delaney SM; Fackenthal DL; Das S; Dolan ME
    Cancer Res; 2008 May; 68(9):3161-8. PubMed ID: 18451141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome.
    Dausset J; Cann H; Cohen D; Lathrop M; Lalouel JM; White R
    Genomics; 1990 Mar; 6(3):575-7. PubMed ID: 2184120
    [No Abstract]   [Full Text] [Related]  

  • 54. Identification and replication of loci involved in camptothecin-induced cytotoxicity using CEPH pedigrees.
    Watson VG; Motsinger-Reif A; Hardison NE; Peters EJ; Havener TM; Everitt L; Auman JT; Comins DL; McLeod HL
    PLoS One; 2011 May; 6(5):e17561. PubMed ID: 21573211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines.
    Stark AL; Zhang W; Mi S; Duan S; O'Donnell PH; Huang RS; Dolan ME
    Pharmacogenomics J; 2010 Dec; 10(6):505-12. PubMed ID: 20142840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CEPH maps.
    Cann HM
    Curr Opin Genet Dev; 1992 Jun; 2(3):393-9. PubMed ID: 1504612
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A genome-wide linkage study of GAW15 gene expression data.
    Kan D; Cooper R; Zhu X
    BMC Proc; 2007; 1 Suppl 1(Suppl 1):S87. PubMed ID: 18466590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of strategies for identification of regulatory quantitative trait loci of transcript expression traits.
    Franceschini N; Wojczynski MK; Göring HH; Peralta JM; Dyer TD; Li X; Li H; North KE
    BMC Proc; 2007; 1 Suppl 1(Suppl 1):S85. PubMed ID: 18466588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Normalization of microarray expression data using within-pedigree pool and its effect on linkage analysis.
    Kim Y; Doan BQ; Duggal P; Bailey-Wilson JE
    BMC Proc; 2007; 1 Suppl 1(Suppl 1):S152. PubMed ID: 18466497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacogenetics of resistance to Cisplatin and other anticancer drugs and the role of sphingolipid metabolism.
    Alexander S; Swatson WS; Alexander H
    Methods Mol Biol; 2013; 983():185-204. PubMed ID: 23494308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.